Scientific Program

Program Overview

Friday, 7 November 2025
8:00-9:00 Registration
SESSION 1
9:00-9:05 Introduction and Welcome
Morgentaler
9:05-9:20 The Importance of Testosterone in Men’s Health
Morgentaler
9:20-9:40 History of Testosterone Therapy: Where We Have Been and Where We Are Going
Traish
9:40-10:00 Testosterone Does Not Drive Prostate Cancer: Death of a Once-Foundational Concept
Morgentaler
10:00-10:20 Physiology and Pathophysiology of Testosterone Deficiency
Traish
10:20-10:30 Question-and-Answer Session
10:30-10:50 Refreshment Break
SESSION 2
10:50-11:10 The Role of CAG Repeats on Androgen Receptor
Jones
11:10-11:30 GLP1 Medications: Is There a Role for Testosterone Therapy?
Zitzmann
11:30-11:50 Re-evaluating the Role of Free T and SHBG
Antonio
11:50-12:10 Who Is a Candidate? The Marriage of Guidelines and Clinical Experience for Testosterone Therapy
Morgentaler
12:10-12:20 Question-and-Answer Session
12:20-13:20 Lunch Break (Celia Restaurant)
SESSION 3
13:20-13:40 What Have We Learned from the Large RCT’s?
Antonio
13:40-14:00 Insights from a Patient: Understanding Testosterone Deficiency
Hackett
14:00-14:20 Real-World Data on T Therapy – Outcomes of Cardiometabolic and Prostate Events: A 17 Year Experience
Saad
14:20-14:50 How Has the Traverse Study Influenced Clinical Practice
Antonio, Hackett, Khera, Zitzmann
14:50-15:00 Question-and-Answer Session
15:00-15:20 Refreshment Break
SESSION 4
15:20-15:40 Addressing the X Factor in Human Sexuality
Brandon
15:40-16:00 Impact of Testosterone on Depression and Mental Health
David
16:00-16:20 New Approaches to Management of Young, Fertile, Men with Testosterone Deficiency
Khera
16:20-16:50 Question-and-Answer Session

 

Saturday, 8 November 2025
8:00-9:00 Registration
SESSION 5
9:00-9:15 Platelet-Rich Plasma (PRP) and Shockwave Therapy (SWT) for Erectile Dysfunction: What’s the Evidence?
Khera
9:15-9:30 A Sex Therapist’s Approach to Low Libido
Brandon
9:30-9:45 Should Testosterone Therapy Be A Routine Consideration in the Management of Type 2 Diabetes in Men?
Jones
9:45-10:00 Testosterone Therapy, Erythrocytosis and Thrombosis
Zitzmann
10:00-10:20 The Future of Intimacy
Brandon
10:20-10:30 Question-and-Answer Session
10:30-10:50 Refreshment Break
SESSION 6
10:50-11:15 Management of Complex Clinical Cases: A Case-Based Session
David, Jones, Khera, Zitzmann
11:15-11:30 Quality of Life in Testosterone: Treated Men with Normal Total T
TBD
11:30-12:15 KEYNOTE: Testosterone, Science and Human Dignity
Morgentaler
12:15-13:15 Lunch Break (Celia Restaurant)
SESSION 7
13:15-13:35 Opioids and Testosterone
David
13:35-13:50 What I See for the Future of Testosterone Therapy
Morgentaler
13:50-15:00 Question-and-Answer Session

NOTE: All sessions are held at the Kimpton de Witt Amsterdam and are located on the ground floor.

Program Director

Abraham Morgentaler, MD, FACS

Scientific Advisory Committee

Abdul Traish, PhD
Michael Zitzmann, MD, PhD, FRSM, FECSM

Earn Up To

Credits are pending

Who Should Attend?

This program provides education for:
• Endocrinologist
• Urologists
• Family practice providers
• Primary care providers
• Geriatricians
• Other clinicians who treat low testosterone and male sexual health issues